BIOHIT'S ANNUAL REPORT 2008 HAS BEEN PUBLISHED


BIOHIT OYJ STOCK EXCHANGE ANNOUNCEMENT ON 16 APRIL 2009 AT 4:00 PM              

BIOHIT'S ANNUAL REPORT 2008 HAS BEEN PUBLISHED                                  

The Annual Report 2008 is now available in Finnish and English on Biohit's web  
site at www.biohit.com/investors. The Annual Report includes the previously     
published financial statements, the report of the Board of Directors and the    
auditors' report, as well as the annual summary for 2008.                       

Hardcopies of the Annual Report may be ordered from Biohit, via telephone:      
+358-9-773 861, via email: info@biohit.com or via the order form at Biohit's 
website.                                                                        


Josefin Hoviniemi
Marketing & Communications Director                                           
Biohit Oyj                                                                      

Distribution:                                                                   

NASDAQ OMX Helsinki Oy                                                          
Central storage facility (www.oam.fi)                                           
Press                                                                           
www.biohit.com                                                                  


About Biohit Oyj                                                                

Biohit Oyj develops, manufactures and markets liquid handling products and      
diagnostic test systems for use in research, health care and industrial         
laboratories.                                                                   

Liquid handling products include electronic and mechanical pipettes and         
dispensers, and disposable tips, as well as pipette maintenance and calibration 
services. Diagnostics business comprises products and analysis systems for      
diagnosing, screening and prevention of gastrointestinal diseases, e.g. the     
blood-sample based GastroPanel and GastroView, for diagnosing diseases of the   
stomach and associated risks, as well as quick tests for the diagnosis of       
lactose intolerance, H. pylori infection and fecal occult blood.                

Biohit Oyj is headquartered in Finland. Biohit has subsidiaries in France,      
Germany, the UK, Russia, China, Japan and the USA. Additionally, Biohit's       
products are sold by approximately 450 distributors in 70 countries. Biohit's   
share (BIOBV) is quoted on NASDAQ OMX Helsinki.                                 

Read more at www.biohit.com

Attachments

biohit-annualreport-2008-screen.pdf